MeSH term
Frequency | Condition_Probility | Humans | 22 | 0.0 |
Research Support, Non-U.S. Gov't | 12 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Adult | 6 | 0.0 |
Comparative Study | 4 | 0.0 |
Female | 8 | 0.0 |
Male | 7 | 0.0 |
Middle Aged | 5 | 0.0 |
Prognosis | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Statistics, Nonparametric | 2 | 0.0 |
Aged | 4 | 0.0 |
Genotype | 3 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Animals | 2 | 0.0 |
Mice | 2 | 0.0 |
Alleles | 3 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Gene Frequency | 2 | 0.0 |
Genetic Markers | 4 | 0.0 |
Receptors, Interleukin-6/*genetics | 2 | 66.0 |
Base Sequence | 2 | 0.0 |
Chromosomes, Human, Pair 1/*genetics | 2 | 0.0 |
Consanguinity | 2 | 0.0 |
Genes, Recessive | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Molecular Sequence Data | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Receptors, Interleukin-6 | 7 | 8.0 |
Antibodies, Monoclonal | 2 | 0.0 |
B-Lymphocytes/*immunology | 2 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
English Abstract | 2 | 0.0 |
